Evidence map›Paper›PMID 20507740›Full record

ArticleEmerging infectious diseases2010

Evolution of northeastern and midwestern Borrelia burgdorferi, United States.

Dustin Brisson, Mary F Vandermause, Jennifer K Meece, Kurt D Reed, Daniel E Dykhuizen

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Diversity and host specificity ofInfection and immunity · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Evolutionary ecology of Lyme Borrelia.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Evolutionary aspects of emerging Lyme disease in Canada.Applied and environmental microbiology · 2015
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dustin BrissonDepartment of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6018, USA. dbrisson@sas.upenn.edu
Mary F Vandermause
Jennifer K Meece
Kurt D Reed
Daniel E Dykhuizen

Funding

AN EVOLUTIONARY ANALYSIS OF FIMBRIAE IN ENTEROBACTERIAR01GM060731 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DYKHUIZEN, DANIEL E. · 2000 to 2007
$2.6M
Causes and consequences of ospC variation in Borrelia burgdorferi to Lyme diseaseR01AI076342 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRISSON, DUSTIN · 2008 to 2011
$1.4M
NCEZID CDC HHS U01CK000170NIAID NIH HHS AI076342NIAID NIH HHS R01 AI076342NIGMS NIH HHS GM31912NIGMS NIH HHS R01 GM060731
6 · The paper itself

Abstract

The per capita incidence of human Lyme disease in the northeastern United States is more than twice that in the Midwest. However, the prevalence of Borrelia burgdorferi, the bacterium that causes Lyme disease, in the tick vector is nearly identical in the 2 regions. The disparity in human Lyme disease incidence may result from a disparity in the human invasiveness of the bacteria in the Northeast and Midwest caused by fundamentally different evolutionary histories. B. burgdorferi populations in the Northeast and Midwest are geographically isolated, enabling evolutionary divergence in human invasiveness. However, we found that B. burgdorferi populations in the Northeast and Midwest shared a recent common ancestor, which suggests that substantial evolutionary divergence in human invasiveness has not occurred. We propose that differences in either animal ecology or human behavior are the root cause of the differences in human incidence between the 2 regions.

Indexed as

Evolution, MolecularAnimalsAntigens, BacterialAntigens, SurfaceArachnid VectorsBacterial Outer Membrane ProteinsBacterial VaccinesBorrelia burgdorferiDNA, BacterialGenetic VariationHumansLipoproteinsLyme DiseaseMidwestern United StatesNew EnglandPhylogenyAntigens, BacterialAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial VaccinesDNA, BacterialLipoproteinsOspA proteinOspB protein, Borrelia burgdorferiOspC proteinRNA, Ribosomal

Identifiers

PMID20507740
PMCPMC3086229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.